Vimarsana
Biggest News Aggregation in the World

Page 25 - Boxed Warning News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Boxed Warning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Boxed Warning Today - Breaking & Trending Today

Endo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting - Vimarsana News

Endo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting

/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that five new presentations related to Peyronie's disease, or PD, and XIAFLEX® (collagenase...

Likmez, an Oral Suspension Formulation of Metronidazole, Now Available - Vimarsana News

Likmez, an Oral Suspension Formulation of Metronidazole, Now Available

Likmez, a ready-to-use oral suspension of metronidazole, has been made available by Kesin Pharma Corporation.

Source: empr.com
Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK, Nov. 15, 2023 /PRNewswire/ -- Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the...

Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and...

Aurinia Pharmaceuticals Announces Collaboration Partner Otsuka Filed New Drug Application (NDA) for LUPKYNIS® (Voclosporin) in Japan - Vimarsana News

Aurinia Pharmaceuticals Announces Collaboration Partner Otsuka Filed New Drug Application (NDA) for LUPKYNIS® (Voclosporin) in Japan

ROCKVILLE, Md. & EDMONTON, Alberta, November 13, 2023--Aurinia Pharmaceuticals Announces Collaboration Partner Otsuka Filed New Drug Application (NDA) for LUPKYNIS® (Voclosporin) in Japan

Source: yahoo.com